Duke Street

Acting for private equity fund Duke Street on the Irish aspects of the acquisition of DCC’s generic drug business with operations in Ireland and Britain.

The deal included British drugs business Kent Pharmaceuticals and an associated Irish manufacturer, Athlone Laboratories.

Duke Street, a London-based private equity house, is a prolific acquirer of medium-sized business across Europe across a broad range of sectors.

More information available here.

Corporate partner Jonathan Kelly and corporate consultant Ita O’Sullivan led the Philip Lee team.

Key Contacts

Key Contacts

News and insights

M&A Insights H1 2023 – A cross-border deal insight guide

M&A Insights H1 2023 – A cross-border deal insight guide

Key Contacts: Eoghan Doyle - Partner  |  Andrew Tzialli - Partner We are delighted to introduce the fifth edition of the Philip Lee M&A Insights guide. In this edition, we review deal activity across H1 2023, and consider the outlook for the rest of the year...

read more
The Web3 passport

The Web3 passport

Key Contacts: Andrew Tzialli - Partner  | Head of blockchain and crypto assets, Andrew Tzialli, spoke to the Web3 passport in their latest podcast to discuss the world of blockchain and digital assets. The Web3 passport podcast explores areas such as Web3, blockchain,...

read more
Share This